Feedback / Questions
ALLO-316 - Allogene Overland Biopharm
https://www.globenewswire.com/news-release/2025/06/01/3091475/0/en/Allogene-Therapeutics-Provides-Updated-Phase-1-Data-Highlighting-Durable-Responses-with-ALLO-316-in-Heavily-Pretreated-Advanced-Renal-Cell-Carcinoma-at-ASCO.html
Jun 1, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next